Ensign Peak Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24M | Sell |
|
|||||
|
2025
Q1 | $4.41M | Buy |
|
|||||
|
2024
Q4 | $4.07M | Sell |
|
|||||
|
2024
Q3 | $4.77M | Sell |
|
|||||
|
2024
Q2 | $5.92M | Sell |
|
|||||
|
2024
Q1 | $6.3M | Sell |
|
|||||
|
2023
Q4 | $15.2M | Buy |
|
|||||
|
2023
Q3 | $10.6M | Sell |
|
|||||
|
2023
Q2 | $10.6M | Buy |
|
|||||
|
2023
Q1 | $10.3M | Sell |
|
|||||
|
2022
Q4 | $25.1M | Buy |
|
|||||
|
2022
Q3 | $18.6M | Buy |
|
|||||
|
2022
Q2 | $7.49M | Buy |
|
|||||
|
2022
Q1 | $3.5M | Sell |
|
|||||
|
2021
Q4 | $4.7M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.25M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $892K | Buy |
|